Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2023-08-25
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Percutaneous Dilatational Tracheostomy vs. Surgical Tracheostomy in Neurocritically Ill Patients - a Retrospective Study
NCT06018220
WEANING FROM TRACHEOSTOMY
NCT05271786
Interventional Therapy of Tracheal Stenosis
NCT05924087
Routine Use of FIBERoptic Bronchoscopic Guidance in Percutaneous TRACHeostomy
NCT04265625
Navigation System for Percutaneous Tracheotomy
NCT04744909
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
\- to evaluate the rate of physical complications (that require treatment, intubation, recannulation or lead to death) in patients hospitalized in the SPC over three months following the removal of the tracheal cannula (decannulation).
Secondary objectives
* to describe types of complications short-term (up to 4 days) and long-term (up to three months) post-decannulation
* to assess predictors for short- and long-term complications post-decannulation
* to explore patients' perspectives on decannulation outcomes
* to evaluate individual trajectories of the clinical decannulation protocol
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* decannulated in the Swiss Paraplegic Center Nottwil within the project's data collection period
* German, French, Italian or English as communication language
* study consent
Exclusion Criteria
* patients for whom decannulation is planned in a clinic other than the SPC (e.g., patients hospitalized in the SPC for weaning only)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swiss Paraplegic Research, Nottwil
NETWORK
Katharina Winiker
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katharina Winiker
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Katharina Winiker, PhD
Role: PRINCIPAL_INVESTIGATOR
Swiss University of Speech and Language Sciences
Gabi Müller Verbiest, PhD
Role: STUDY_CHAIR
Swiss Paraplegic Center Nottwil
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Swiss Paraplegic Center Nottwil
Nottwil, Canton of Lucerne, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.